Secretin is a 27-amino acid neuroendocrine peptide that stimulates flu
id and electrolyte secretion in the gastrointestinal tract, activates
tyrosine hydroxylase activity in the central nervous system, and affec
ts cardiac and renal function. Specific receptors for secretin have be
en previously characterized on neuroblastoma cells, pancreatic acini,
gastric glands, and liver cholangiocytes. We report here the isolation
of a 1616-base pair cDNA from human lung tissue that encodes a 440-am
ino acid, 50-kDa, G protein-coupled human secretin receptor (HSR), wit
h homology of 80% with the rat secretin receptor and 37% with the huma
n type I vasoactive intestinal peptide receptor. Northern blot analysi
s of human tissue mRNA revealed that the relative intensity for expres
sion of a 2.1-kilobase HSR transcript was pancreas > kidney > small in
testine > lung > liver, with trace levels in brain, heart, and ovary.
Stable transfectants of HSR in human embryonic kidney 293 cells, terme
d 293S12, expressed 10(5) binding sites/cell for I-125-secretin, with
an apparent K-d of 3.2 nM. Vasoactive intestinal peptide, pituitary ad
enylyl cyclase-activating peptide-38, and glucagon were less potent (b
y 3 orders of magnitude) than secretin in competitively inhibiting I-1
25-secretin binding to 293S12 cells. Secretin evoked concurrent dose-d
ependent increases in intracellular cAMP and calcium levels in 293S12
cells and stimulated a 4-fold increase in phosphatidytinositol hydroly
sis. Thus, the HSR expressed by stable transfectants can couple to two
distinct intracellular signaling pathways.